Malignant melanoma with adjacent intraepidermal proliferation.
D000328:Adult; D014128:Chromomycin A3 / Q000627:therapeutic use; D005006:Ethnicity; D005260:Female; D006365:Heel / Q000473:pathology; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007911:Lentigo / Q000473:pathology; D008048:Lip Neoplasms / Q000473:pathology* / Q000601:surgery; D008175:Lung Neoplasms; D008207:Lymphatic Metastasis; D008297:Male; D008544:Melanocytes / Q000473:pathology*; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D008875:Middle Aged; D008937:Mitomycins / Q000627:therapeutic use; D011379:Prognosis; D012878:Skin Neoplasms / Q000473:pathology* / Q000628:therapy; D013933:Thumb / Q000473:pathology; D014846:Vulvar Neoplasms / Q000188:drug therapy / Q000473:pathology*
D008937:Mitomycins; D014128:Chromomycin A3; D006918:Hydroxyurea